News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

MGI PHARMA, INC. (MOGN) Release: Notice of Correction to Notice of Conversion Right for Senior Subordinated Convertible Notes Due 2024


1/8/2008 9:28:21 AM

BLOOMINGTON, Minn.--(BUSINESS WIRE)--On December 26, 2007, MGI PHARMA, INC. issued a Notice of Conversion Right to holders of its Senior Subordinated Convertible Notes due 2024. The notice incorrectly listed February 15, 2007 as the date after which any note surrendered for conversion would also be entitled to payment of interest on the note otherwise due on March 3, 2008. The correct date is February 15, 2008. The full text of the notice, as corrected, is set forth below.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES